| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 462,410 | 470,229 | 426,747 | 483,365 | | Cost of Revenue | 197,555 | 224,056 | 189,889 | 310,842 | | | Gross Profit | 264,855 | 246,173 | 236,858 | 172,523 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 246,200 | 239,429 | 239,390 | 262,528 | | Non Recurring | 15,948 | 31,907 | 185 | 349,122 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,707 | (25,163) | (2,717) | (439,127) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 186 | 291 | 273 | 106 | | Earnings Before Interest And Taxes | 2,893 | (24,872) | (2,444) | (439,021) | | Interest Expense | 788 | 1,031 | 779 | 437 | | Income Before Tax | 2,105 | (25,903) | (3,223) | (439,458) | | Income Tax Expense | 36 | (7,899) | (909) | (63,852) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,069 | (18,004) | (2,314) | (375,606) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,069 | (18,004) | (2,314) | (375,606) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,069 | ($18,004) | ($2,314) | ($375,606) |
|
0.31% Nasdaq 0.00%
Income Statement
